ScholarIQanswers from OpenAlex
Parathyroid Disorders and Treatments
TopicLeading institutions, researchers & key papers
Parathyroid Disorders and Treatments is a topic indexed in ScholarIQ from OpenAlex.
What is known about Parathyroid Disorders and Treatments?
ScholarIQrecord summary
This cluster of papers focuses on the complex interplay of FGF23, phosphate, calcification, and mineral metabolism in the context of chronic kidney disease. It explores the role of parathyroid hormone, vascular health, and the impact of Klotho deficiency on mineral homeostasis. The cluster also delves into the implications of hyperphosphatemia and calcification on cardiovascular risk in patients with chronic kidney disease.
How many works does Parathyroid Disorders and Treatments have?
ScholarIQindexed works
Parathyroid Disorders and Treatments has 565 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Parathyroid Disorders and Treatments?
ScholarIQopenalex
The OpenAlex for Parathyroid Disorders and Treatments is on the source record.
What are the most-cited papers on Parathyroid Disorders and Treatments?
ScholarIQmost cited works
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Geoffrey A. Block, Preston Klassen, J. Michael Lazarus, Norma J. Ofsthun, Edmund G. Lowrie, Glenn M. Chertow
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow, Keith A. Hruska, Craig B. Langman, Hartmut H. Malluche, Kévin Martin, Linda McCann, James T. McCarthy, Sharon M. Moe, Isidro B. Salusky, Donald J. Sherrand, Miroslaw Smogorzewski, Kline Bolton, Charles M. Turkelson, Karyn A. Tappe, Stephen Tregear, James Reston, Wendy Bruening, Mark Monteforte, Janice L Kaczmarek, Vivian Coates, George R. Bailie, Bryan Becker, Gavin J. Becker, Jerrilynn D. Burrowes, Fernando Carrera, David Churchill, Alan Collins, Peter Crooks, Dick de Zeeuw, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Roger Greenwood, Joel Greer, Richard H. Grimm, William E. Haley, Ronald J. Hogg, Alan R. Hull, Lawrence G. Hunsicker, Cynda Ann Johnson, Michael J. Klag, Saulo Klahr, Norbert Lameire, Francesco Locatelli, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, Gregorio T. Obrador, William F. Owen, Thakor G. Patel, Glenda M. Payne, Claudio Ronco, Rosa A. Rivera-Mizzoni, Anton C. Schoolwerth, Robert A. Star, Michael W. Steffes, Theodore I. Steinman, John Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs, Thomas H. Hostetter, Garabed Eknoyan, Aderra Levin, Nathan W. Levin, Sharon Andreoli, S Burrows-Hudson, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Brian J.G. Pereira, Nadine Ferguson, Donna Fingerhut, Anthony Gucciardo, Margaret Klette, Doreen Mallard, Kerry Willis
FGF23 induces left ventricular hypertrophy
Christian Faul, Ansel P. Amaral, Behzad N. Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, Robier Aguillon-Prada, Joy Lincoln, Joshua M. Hare, Peter Mündel, Azorides R. Morales, Julia J. Scialla, Michael J. Fischer, Elsayed Z. Soliman, Jing Chen, Alan S. Go, Sylvia E. Rosas, Lisa Nessel, Raymond R. Townsend, Harold I. Feldman, Martin St. John Sutton, Akinlolu Ojo, Crystal A. Gadegbeku, Giovana Seno Di Marco, Stefan Reuter, Dominik Kentrup, Klaus Tiemann, Marcus Brand, Joseph A. Hill, Orson W. Moe, Makoto Kuro‐o, John W. Kusek, Martin Keane, Myles Wolf
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
Kenneth E. White, W. Evans, Jeffery L.H. O'Riordan, Marcy C. Speer, Michael J. Econs, Bettina Lorenz‐Depiereux, Monika Grabowski, Thomas Meitinger, Tim M. Strom
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
Adeera Levin, George L. Bakris, Mark E. Molitch, Maartje Smulders, Jianhua Tian, Laura Williams, D.L. Andress
Where is Parathyroid Disorders and Treatments research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Parathyroid Disorders and Treatments is open access?
ScholarIQopen access share
33%OPEN ACCESS